Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

Royalty Pharma plc ( RPRX ) delivered decent financials in 2025. We saw double-digit growth in both Royalty Receipts and Portfolio Receipts. This led to very good returns on invested capital for the company. Elsewhere capital deployment remainedI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundatio ...